FDA approves Farxiga to reduce risk of hospitalization for heart failure in type 2 diabetes patients Oct. 21, 2019
First clinical trial of an extracellular matrix hydrogel in post-myocardial infarction patients Oct. 16, 2019
PARAGON-HF results for sacubitril/valsartan in heart failure with preserved ejection fraction Oct. 4, 2019
Phase II data presented for ampreloxetine as treatment of neurogenic orthostatic hypotension Oct. 2, 2019
RSS